Primo Chemicals Q1 FY27 Profit Rises to ₹523.66 Crore
Primo Chemicals reported standalone profit after tax of ₹523.66 crore for Q1 FY27, up from ₹480.79 crore in Q1 FY26. Consolidated profit after tax was ₹537.08 crore on revenue of ₹4,156.88 crore. The company is proceeding to make Flow Tech Chemicals a wholly-owned subsidiary.
The increase in profits and revenue, along with the strategic move to acquire full ownership of a subsidiary, are significant developments for the company, impacting its financial standing and future growth prospects.
The company reported an increase in profit after tax on both standalone and consolidated bases compared to the previous year's corresponding quarter, indicating positive financial performance.
Primo Chemicals Limited announced its unaudited financial results for the quarter ended June 30, 2026. The company's Board of Directors approved the results at a meeting held on August 14, 2026, which commenced at 12:30 PM and concluded at 4:35 PM.
On a standalone basis, the company reported a total revenue of ₹4,012.51 crore for the quarter. The profit after tax for the quarter stood at ₹523.66 crore, compared to ₹480.79 crore in the same quarter of the previous fiscal year (ended June 30, 2025). Earnings per share (EPS) for the quarter were ₹2.00.
The company also presented consolidated financial results. The consolidated profit after tax for the quarter ended June 30, 2026, was ₹537.08 crore. The consolidated total revenue for the same period was ₹4,156.88 crore.
Primo Chemicals Limited has a 49% equity stake in M/s Flow Tech Chemicals (P) Limited, which is treated as an associate concern. The company is in the process of making Flow Tech Chemicals Private Limited a wholly-owned subsidiary, following approvals from the Board of Directors on July 2, 2026, and shareholders on August 5, 2026.
The company operates in a single business segment: Chemicals. The figures for previous periods have been regrouped or reclassified where necessary. The results were reviewed by the Audit Committee before being approved by the Board.
What to do with a filing like this
Primo Chemicals Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Primo Chemicals Limited. Read the original for the full detail.